Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis

Expert Review of Neurotherapeutics
Izabella LejbkowiczAriel Miller

Abstract

The current understanding that the key for successful healthcare is an integrated approach, involving predictive, preventive, personalized and participatory medicine, is leading major changes. These are: a shift from medical decisions based on 'trial and error' to informed therapeutics based on diagnostics (theranostics); a shift from a 'disease-centered' to a 'patient-centered' approach; and a shift from a 'reactive' to 'proactive' medical approach. It is essential that not only the physician, but also the patient, becomes proactive. Therefore, beyond the integration of genomic medicine and predictive biomarkers into practice, patient empowerment and participatory medicine are gaining increasing attention. This requires, besides appropriate sharing of information between patients and healthcare providers, new insights in patient involvement, such as patient-reported outcomes, both at the clinical trial stage of drug development and during post-marketing follow-up assessments. Patient empowerment and participatory medicine, as part of predictive, preventive, personalized and participatory medicine, are especially crucial in paving the way towards optimized healthcare in complex and chronic neurological diseases, such as multipl...Continue Reading

References

Jun 1, 1992·British Journal of Addiction·J O ProchaskaJ S Rossi
Apr 1, 1985·Annals of Internal Medicine·S GreenfieldJ E Ware
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·B G VickreyG W Ellison
Sep 1, 1999·Multiple Sclerosis : Clinical and Laboratory Research·J S FischerD Paty
Oct 12, 1999·Multiple Sclerosis : Clinical and Laboratory Research·M J HoholH L Weiner
Dec 22, 1999·American Journal of Preventive Medicine·D L Frosch, R M Kaplan
Mar 15, 2001·International Journal of Medical Informatics·M J Ball, J Lillis
May 4, 2001·Brain : a Journal of Neurology·J HobartA Thompson
Apr 17, 2002·Journal of Medical Internet Research·Henry W W Potts, Jeremy C Wyatt
Sep 1, 2005·Journal of the American Pharmacists Association : JAPhA·Bruce A BergerKaren Suchanek Hudmon
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Sep 5, 2006·Pain·Olympia HadjimichaelTimothy Vollmer
Oct 31, 2006·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·Ann Chiovetti
Jul 12, 2007·Pharmacogenetics and Genomics·Iris GrossmanAriel Miller
Sep 21, 2007·Multiple Sclerosis : Clinical and Laboratory Research·R W Motl, J L Gosney
Oct 31, 2007·Multiple Sclerosis : Clinical and Laboratory Research·A P TurnerJ K Haselkorn
Dec 7, 2007·Journal of the Neurological Sciences·Robert W Motl, Erin M Snook
Apr 3, 2008·Arthritis and Rheumatism·M Cameron HayDaniel E Furst
Aug 30, 2008·Multiple Sclerosis : Clinical and Laboratory Research·Rj MillsA Tennant
Sep 16, 2008·Journal of the Neurological Sciences·Ariel MillerTamar Paperna
Oct 25, 2008·Neurorehabilitation and Neural Repair·Erin M Snook, Robert W Motl
Dec 9, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·P ZamboniF Salvi
Dec 17, 2008·Neurology·M DaumerG C Ebers
Mar 3, 2009·Lancet·Andrew D GoodmanUNKNOWN Fampridine MS-F203 Investigators
Mar 28, 2009·Journal of Neurology·Thomas Klauer, Uwe K Zettl
May 16, 2009·Journal of Neurology·Katherine TreadawayElliot M Frohman
Jun 13, 2009·Science·Mark S BoguskiVikas P Sukhatme
Nov 18, 2009·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Robert W Motl, Edward McAuley
Dec 10, 2009·Multiple Sclerosis : Clinical and Laboratory Research·Jared M BruceSharon G Lynch
Jan 15, 2010·Annual Review of Public Health·Artemis P Simopoulos
Jan 29, 2010·Acta Paediatrica·Robert S Fisher
Feb 4, 2010·Journal of Behavioral Medicine·Jared M BruceSharon Lynch
Feb 24, 2010·Disability and Rehabilitation·Frances Twomey, Katie Robinson
Mar 12, 2010·The New England Journal of Medicine·Ethan Basch
Jun 22, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·V DevonshireUNKNOWN GAP Study Group
Jul 9, 2010·Current Pharmacogenomics and Personalized Medicine·V OzdemirM Z Salleh

❮ Previous
Next ❯

Citations

Dec 24, 2013·Genome Medicine·Leroy Hood, Charles Auffray
Oct 9, 2012·Expert Review of Neurotherapeutics·C HeesenS M Gold
Sep 20, 2015·Neurología : publicación oficial de la Sociedad Española de Neurología·A Muñoz San JoséC Bayón Pérez
Nov 13, 2012·The EPMA Journal·Tatiana A BodrovaSergey V Suchkov
Jun 16, 2016·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·Mohammad SahebalzamaniPedram Paragomi
Mar 31, 2017·Disability and Rehabilitation·Martina BorghiEmanuela Calandri
Mar 10, 2018·Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy·Alham Al-SharmanMais AlDughmi
Jul 15, 2015·Journal of Medical Systems·Georgy Kopanitsa
Oct 30, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giampaolo BrichettoAndrea Tacchino
Dec 2, 2020·International Journal of Environmental Research and Public Health·Michela FranchiniDaniele Della Latta
Feb 1, 2020·Multiple Sclerosis and Related Disorders·Efrat NeterAriel Miller
Jun 17, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Rachel L HarringtonEleanor M Perfetto
Aug 6, 2021·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Nick BansbackRobert Carruthers
Dec 12, 2020·European Journal of Physical and Rehabilitation Medicine·Valeria PradaMargherita Monti Bragadin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Medical Devices
Simon ExellReinoud Driebergen
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
J-B Ricco, A R Naylor
© 2022 Meta ULC. All rights reserved